North America Hysterectomy Device Market Size, Share & Industry Trends Analysis Report by Disease Type, End User, Surgical Approach, Country and Growth Forecast, 2022-2028

The North America Hysterectomy Device Market should witness market growth of 4.3% CAGR during the forecast period (2022-2028).

Long-lasting treatment for fibroids is a hysterectomy. Fibroids are uterine tumors that develop. They don't have cancer. These may result in severe bleeding, anemia, pelvic pain, and pressure in the bladder. Endometriosis is a disorder in which tissue that resembles the uterine lining grows outside the uterus. The ovaries, fallopian tubes, and other adjacent organs may experience tissue growth. A hysterectomy that removes the uterus, ovaries, and fallopian tubes may be required for severe endometriosis.

Pelvic prolapse. The uterus may not be adequately supported when the pelvic floor muscles and ligaments stretch and deteriorate. Uterine prolapse is the medical term for when the uterus falls out of its normal position and into the vagina. This disorder may cause urinary leaks, pelvic pressure, and bowel irregularities. Sometimes, this ailment necessitates a hysterectomy. A hysterectomy may relieve the patient from thick periods, uneven or lasting several days each cycle. Only when alternative measures fail to control the bleeding is a hysterectomy performed.

In Canada, 1.3% of all new female cancer cases and 1.1% of all female cancer fatalities are caused by cervical cancer. In 2019, 410 women were predicted to pass away from cervical cancer, and 1,350 new cases were anticipated. It is expected that 1 in 168 women will develop cervical cancer and 1 in 478 will pass away. The cervix's cells alter and become aberrant before cervical cancer manifests. Cervical dysplasia is the name given to this alteration. If left untreated, this precancerous disease can progress to malignancy.

The US market dominated the North America Hysterectomy Device Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $116.3 million by 2028. The Canada market is poised to grow at a CAGR of 6.7% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 5.8% during (2022-2028).

Based on Disease Type, the market is segmented into Chronic Pelvic Pain, Fibroids, Uterine Cancer and Others. Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on Surgical Approach, the market is segmented into Abdominal Hysterectomy, Laparoscopic Hysterectomy, Robotic-assisted Laparoscopic Hysterectomy and Vaginal Hysterectomy. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, B. Braun Melsungen AG, ConMed Corporation, Johnson & Johnson, Richard Wolf GmbH, Karl Storz SE & Co. KG, The Cooper Companies, Inc., Laborie Medical Technologies (Patricia Industries) (Investor AB), Fortimedix Surgical B.V., and Conkin Surgical Instruments Ltd.

Scope of the Study

By Disease Type

• Chronic Pelvic Pain
• Fibroids
• Uterine Cancer
• Others

By End-user

• Hospitals
• Ambulatory Surgical Centers
• Others

By Surgical Approach

• Abdominal Hysterectomy
• Laparoscopic Hysterectomy
• Robotic-assisted Laparoscopic Hysterectomy
• Vaginal Hysterectomy

By Country

• US
• Canada
• Mexico
• Rest of North America

Key Market Players

List of Companies Profiled in the Report:

• Medtronic PLC
• B.Braun Melsungen AG
• ConMed Corporation
• Johnson & Johnson
• Richard Wolf GmbH
• Karl Storz SE & Co. KG
• The Cooper Companies, Inc.
• Laborie Medical Technologies ( Patricia Industries)(Investor AB)
• Fortimedix Surgical B.V.
• Conkin Surgical Instruments Ltd

Unique Offerings

• Exhaustive coverage
• The highest number of Market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free